Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis.
Hope and challenges for dendritic cell-based vaccine therapy for glioblastoma.
Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.
The spectrum of vaccine therapies for patients with glioblastoma multiforme.
A viral strategy to ambush tumors.
Treatment of glioma by engineered interleukin 4-secreting cells.
An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma.
Oncolytic viruses and their application to cancer immunotherapy.
Immunotherapy advances for glioblastoma.
Oncolytic Virus-Mediated Immunotherapy: A Combinatorial Approach for Cancer Treatment.
Cancer immunotherapy: A vaccine from plant virus proteins.
Current State of Immune-Based Therapies for Glioblastoma.
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.
Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma.
Immunotherapy for glioblastoma: on the sidelines or in the game?
Immunotherapy for glioblastoma: going viral.
Molecular responses to immune checkpoint blockade in glioblastoma.